ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

Bush Vetoes HHS Budget Bill, House Votes To Sustain.

November 23, 2007

“Bring Contracts Under Control, Save $100,00 A Year,” Samuels Tells NCI

November 2, 1979

QOL Of Young Survivors Equal To Other Children

February 25, 2005

NRSAs Renamed For Kirschstein.

June 21, 2002

Funding Opportunities (8-page issue).

April 25, 2003

Recompetitions Of DCT Contracts Okayed

March 3, 1989